McGuire Investment Group, LLC - SELECT SECTOR SPDR TR ownership

SELECT SECTOR SPDR TR's ticker is XLV and the CUSIP is 81369Y209. A total of 1,023 filers reported holding SELECT SECTOR SPDR TR in Q4 2019. The put-call ratio across all filers is 2.84 and the average weighting 0.6%.

Quarter-by-quarter ownership
McGuire Investment Group, LLC ownership history of SELECT SECTOR SPDR TR
ValueSharesWeighting
Q3 2023$1,629,745
-1.7%
12,659
+1.3%
0.31%
+1.6%
Q2 2023$1,657,956
+6.1%
12,491
+3.5%
0.31%
-0.3%
Q1 2023$1,562,219
-1.7%
12,067
+3.2%
0.31%
-9.9%
Q4 2022$1,588,928
+17.1%
11,696
+4.4%
0.34%
+11.3%
Q3 2022$1,357,000
+3.4%
11,207
+9.4%
0.31%
+9.2%
Q2 2022$1,313,000
+6.1%
10,242
+13.5%
0.28%
+24.7%
Q1 2022$1,237,000
+1.1%
9,027
+3.9%
0.23%
+12.9%
Q4 2021$1,224,000
+17.8%
8,689
+6.4%
0.20%
+3.1%
Q3 2021$1,039,000
+4.1%
8,164
+3.0%
0.20%
+3.2%
Q2 2021$998,000
+11.1%
7,923
+2.9%
0.19%0.0%
Q1 2021$898,000
-13.2%
7,696
-15.5%
0.19%
-26.2%
Q4 2020$1,034,000
+9.0%
9,111
+1.3%
0.26%
-9.5%
Q3 2020$949,000
+2.9%
8,996
-2.4%
0.28%
-11.6%
Q2 2020$922,000
+14.1%
9,215
+1.1%
0.32%
-4.8%
Q1 2020$808,000
-0.9%
9,118
+14.0%
0.34%
+38.8%
Q4 2019$815,000
+12.1%
8,001
-0.8%
0.24%
+1.7%
Q3 2019$727,000
-3.6%
8,067
-0.8%
0.24%
-0.4%
Q2 2019$754,000
+3.4%
8,134
+2.4%
0.24%0.0%
Q1 2019$729,000
+15.3%
7,947
+8.7%
0.24%0.0%
Q4 2018$632,000
-10.1%
7,308
-1.1%
0.24%
+3.0%
Q3 2018$703,0007,3910.23%
Other shareholders
SELECT SECTOR SPDR TR shareholders Q4 2019
NameSharesValueWeighting ↓
SWISS RE LTD 1,137,930$145,928,00029.20%
Financial Services Advisory Inc 34,996$4,488,00018.34%
LEE JOHNSON CAPITAL MANAGEMENT, LLC 88,537$11,354,00013.51%
Advisors Preferred, LLC 390,898$50,129,00013.06%
CPR Investments Inc. 64,931$8,327,00012.51%
WestEnd Advisors, LLC 3,041,767$390,076,286,00012.29%
Main Management ETF Advisors, LLC 855,750$109,741,00012.19%
Granite Bay Wealth Management, LLC 121,909$15,634,00012.13%
5th Street Advisors, LLC 80,383$10,308,00010.79%
Parker Investment Management, LLC 355,000$45,525,00010.52%
View complete list of SELECT SECTOR SPDR TR shareholders